-
-
-
-
-
-
-
Travere Therapeutics (TVTX) Tops Q4 EPS by 41c
-
-
-
-
-
-
-
Travere Therapeutics to Report Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
Travere Therapeutics to Report Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Travere Therapeutics (TVTX) Tops Q1 EPS by $2.43
-
-
-
-
-
-
-
Travere Therapeutics Provides Corporate Update and 2024 Outlook
-
-
-
-
-
-
-
Travere Therapeutics Reports Second Quarter 2023 Financial Results
-
1,203,724 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

